|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 852.10 PKR | -1.27% |
|
-9.89% | -18.86% |
| Capitalization | 83.42B 299M 259M 234M 224M 407M 27.59B 421M 2.79B 1.11B 13.18B 1.12B 1.1B 47.59B | P/E ratio 2023 * |
-
| P/E ratio 2024 | 23.2x |
|---|---|---|---|---|---|
| Enterprise value | 83.42B 299M 259M 234M 224M 407M 27.59B 421M 2.79B 1.11B 13.18B 1.12B 1.1B 47.59B | EV / Sales 2023 * |
-
| EV / Sales 2024 | - |
| Free-Float |
16.36% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -1.27% | ||
| 1 week | -9.89% | ||
| Current month | -17.25% | ||
| 1 month | -27.88% | ||
| 3 months | -16.75% | ||
| 6 months | -27.79% | ||
| Current year | -18.86% |
| 1 week | 822.29 | 900 | |
| 1 month | 822.29 | 1,181 | |
| Current year | 822.29 | 1,274 | |
| 1 year | 790 | 1,304 | |
| 3 years | 330 | 1,310 | |
| 5 years | 330 | 1,310 | |
| 10 years | 302.1 | 1,310 |
| Manager | Title | Age | Since |
|---|---|---|---|
Syed Anis Ahmed
CEO | Chief Executive Officer | - | 2016-03-31 |
| Director of Finance/CFO | - | 2019-10-31 | |
Raeef Ahmed
CTO | Chief Tech/Sci/R&D Officer | - | 2011-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Syed Anis Ahmed
BRD | Director/Board Member | - | 2009-02-28 |
Seema Khan
BRD | Director/Board Member | - | 2014-06-03 |
Ehsan Ali Malik
CHM | Chairman | - | 2022-05-29 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.27% | -9.89% | -19.89% | +112.55% | 302M | ||
| -2.26% | -0.61% | +18.91% | +210.22% | 893B | ||
| -0.39% | +1.01% | +48.63% | +59.65% | 586B | ||
| -1.01% | -3.00% | +6.28% | +50.54% | 403B | ||
| -0.62% | -9.47% | +3.55% | +20.69% | 338B | ||
| -0.83% | -2.78% | +23.30% | +34.27% | 301B | ||
| -0.33% | -3.19% | +25.47% | +61.94% | 297B | ||
| -0.26% | -0.14% | +24.17% | +7.63% | 287B | ||
| -2.61% | +0.05% | +17.69% | +61.40% | 204B | ||
| -0.54% | +0.05% | +27.39% | +82.65% | 181B | ||
| Average | -0.75% | -2.52% | +17.55% | +70.15% | 348.95B | |
| Weighted average by Cap. | -0.46% | -1.79% | +22.69% | +88.39% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 55.48B 199M 172M 156M 149M 271M 18.35B 280M 1.86B 737M 8.77B 746M 730M 31.65B | 68.18B 244M 212M 192M 183M 333M 22.55B 344M 2.28B 905M 10.78B 917M 897M 38.89B |
| Net income | 262M 938K 814K 736K 702K 1.28M 86.59M 1.32M 8.75M 3.48M 41.37M 3.52M 3.44M 149M | 5.23B 18.75M 16.27M 14.71M 14.04M 25.54M 1.73B 26.44M 175M 69.51M 827M 70.37M 68.87M 2.99B |
| Net Debt | - | - |
Employees
1,406
Sector
Pharmaceuticals
Calendar
03-16 -
Earnings release - Q4 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-03-12 | 852.10 ₨ | -1.27% | 7,664 |
| 26-03-11 | 863.09 ₨ | -1.67% | 63,393 |
| 26-03-10 | 877.77 ₨ | +4.88% | 27,660 |
| 26-03-09 | 836.92 ₨ | -8.40% | 35,788 |
| 26-03-06 | 913.66 ₨ | -3.38% | 5,632 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
852.10PKR
Average target price
1,300.00PKR
Spread / Average Target
+52.56%
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABOT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















